Overview: Imbruvica 140 mg (Ibrutinib)
Imbruvica 140 mg, containing the active ingredient Ibrutinib, is a leading targeted therapy developed by Janssen. As a potent, first-in-class Bruton’s tyrosine kinase (BTK) inhibitor, it is designed to address complex hematologic malignancies by precisely interfering with the specific signaling pathways that drive the proliferation of malignant B-cells.
Mechanism and Clinical Utility
Imbruvica works by forming a stable, covalent bond with the BTK enzyme. This mechanism effectively blocks the signals that promote the survival and growth of abnormal B-cells. It is a vital component in modern oncology protocols for patients requiring targeted interventions for chronic lymphocytic leukemia and other related blood conditions.
Key Therapeutic Benefits
- Targeted BTK Inhibition: Highly specific action against B-cell malignancies, helping to control disease progression at the molecular level.
- Oral Convenience: Formulated as easy-to-administer hard capsules, facilitating a consistent daily treatment regimen.
- Clinical Reliability: A globally trusted therapy by Janssen, backed by extensive clinical research for efficacy in hematology.
- Precise Dosing: Each hard capsule provides 140 mg of Ibrutinib, allowing for accurate adherence to prescribed oncology treatment plans.
Product Details and Usage
As displayed in the product packaging, this presentation contains 90 hard capsules. This volume provides a substantial supply for patients managed under long-term oncology care protocols.
Safety and Storage Guidelines
Administration: Must be taken strictly as prescribed by your oncologist. Do not alter doses without direct medical supervision.
Storage: Keep the capsules in their original packaging in a cool, dry place. Ensure the storage area does not exceed standard room temperature guidelines and remains inaccessible to children.
Healthcare Collaboration: Maintain regular contact with your oncology team and the specialists at El-Masry Pharmacy to manage your therapy effectively and report any concerns promptly.
Disclaimer: Imbruvica is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before initiation.
You can add a rating once you purchase the product through the My Orders page
